Anavex Life Sciences Corp (AVXL)

[MycroftHolmes]

Re: Barriers to Investment

Investors that can tolerate the ups and downs of Phase 1/2 biotechs are already pretty sparse.

And there is a lot of confusion & uncertainty surrounding this new thing called an Adaptive Trial... and an AD drug to boot?

Phase2... 32 patients and no placebo? I would take a pass also.


So there are 5 bridges to understanding that have to crossed:

1) Realize that the FDA is dramatically changing the way it is doing things
2) Identify that the Adaptive Trial design actually provides much more/better information than it appears at first blush
3) Realize that this new direction is hugely positive for small biotechs who used to be at the mercy of Big Pharma
4) Identify that AVXL is in that class of small biotechs that stands to benefit most from this shift in power
5) Look at AVXL's Adaptive Trial results and correctly interpret a positive risk/reward ratio.

All AVXL longs have crossed those bridges while others have not.

And asynchronous information like that... is what opportunity looks like.

Cheers

Mycroft